首页 | 本学科首页   官方微博 | 高级检索  
检索        

同步放化疗治疗晚期胰腺癌临床观察
引用本文:田素萍,史曙霞,杨保卫.同步放化疗治疗晚期胰腺癌临床观察[J].肿瘤基础与临床,2012,25(5):400-402.
作者姓名:田素萍  史曙霞  杨保卫
作者单位:济源市肿瘤医院放疗科,河南,济源,454650
摘    要:目的观察三维适形放疗(3-DCRT)联合吉西他滨同步化疗治疗晚期胰腺癌的疗效和毒副反应。方法 38例晚期胰腺癌患者采用3-DCRT,局部DT:50~56 Gy,20~25次;同时应用吉西他滨1 000mg.m-2,静脉滴注,d1,8,15,每28 d重复。结果 38例患者均可评价疗效,总有效率为76.32%,局部控制率为86.85%。6、12、24个月生存率分别为85.12%、65.21%和14.03%。毒副反应轻微,患者均能耐受。结论 3-DCRT联合吉西他滨同步化疗治疗晚期胰腺癌是安全、有效的。

关 键 词:三维适形放疗  吉西他滨  胰腺癌

Clinical Observation of Concurrent Chemoradiotherapy for Advanced Pancreatic Cancer
Tian Suping , Shi Shuxia , Yang Baowei.Clinical Observation of Concurrent Chemoradiotherapy for Advanced Pancreatic Cancer[J].journal of basic and clinical oncology,2012,25(5):400-402.
Authors:Tian Suping  Shi Shuxia  Yang Baowei
Institution:(Department of Radiotherapy,Jiyuan Tumor Hospital,JiYuan 454650,China)
Abstract:Objective To observe the effect and toxicities of three dimensional conformal radiation therapy(3-DCRT) plus concurrent gemcitabine chemotherapy for advanced pancreatic cancer.Methods Thirty-eight patients with advanced pancreatic cancer received 3-DCRT(50-56 Gy,20-25 times) and gemcitabine(1 000 mg·m-2,d1,8,15,repeated every 28 days) at the same time.Results Of the 38 patients,the total effective rate was 76.32%,the local-regional control rate was 86.85%.The 6-,12-and 24-month survival rates were 85.12%,65.21% and 14.03%,respectively.The toxicities were mild.Conclusion 3-DCRT plus concurrent gemcitabine chemotherapy is safe and effective for advanced pancreatic cancer.
Keywords:three dimensional conformal radiation therapy  gemcitabine  pancreatic cancer
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号